Feasibility study demonstrates a robotic system's precision in targeting uterine fibroids, suggesting potential therapeutic efficacy.
This article describes a Magnetic Resonance Imaging (MRI) -guided High-Intensity Focused Ultrasound (HIFU) robotic system for the treatment of uterine fibroids. The study presents the development and sensor-based accuracy assessment of the robotic system. The positioning accuracy was assessed in free space using a three-dimensional coordinate measuring machine (CMM) and verified in phantom study and ex vivo with porcine tissue. Average positioning accuracy with a standard deviation of 0.37 ± 0.17 mm was achieved with CMM, 0.9 ± 0.4 mm in the phantom study, and 0.9 ± 0.6 mm with porcine tissue. The MRI compatibility of the system was substantiated with signal-to-noise ratio (SNR) analysis. This robotic system has a positioning accuracy of millimeter level, with almost negligible interference to MRI. It has certain feasibility in the treatment of uterine fibroids. Further clinical trials are warranted to confirm therapeutic efficacy and clinical safety for uterine fibroid treatments.
No takes yet. Share an insight, caveat, or question.
LIU et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: